Workflow
Non - brokered private placement
icon
Search documents
Germanium Mining Announces Up To $1.35M Non-Brokered Private Placement
Thenewswire· 2026-03-20 21:00
Core Viewpoint - Germanium Mining Corp. is conducting a non-brokered private placement to raise up to $1,350,000 through the issuance of units and flow-through shares to fund exploration activities in Quebec [1][3]. Group 1: Offering Details - The Offering consists of up to 3,125,000 units priced at $0.24 each and up to 1,875,000 flow-through shares priced at $0.32 each [1]. - Each unit includes one common share and one warrant, allowing the purchase of an additional common share at $0.32 for 24 months [2]. - The proceeds from the flow-through shares will be allocated to eligible Canadian exploration expenses related to the Company's projects [3]. Group 2: Use of Proceeds - The net proceeds from the units will be used for general corporate and working capital purposes [3]. - All qualifying expenditures related to the flow-through shares will be renounced in favor of the subscribers effective December 31, 2026 [3]. Group 3: Regulatory and Corporate Information - The Offering is subject to corporate and regulatory approvals, and may involve a finder's fee to arm's length parties [4]. - Germanium Mining Corp. is focused on mineral exploration in top-tier mining jurisdictions across North America and is a member of the Nevada Mining Association [5].
BULGOLD Announces Non-Brokered Private Placement for Gross Proceeds of Up to $1.2 Million
Globenewswire· 2026-03-19 11:00
Core Viewpoint - BULGOLD Inc. is initiating a non-brokered private placement to raise between $1,000,000 and $1,200,000 through the issuance of common shares priced at $0.05 each, aimed at funding exploration and development projects, particularly the Lutila Gold Project in Slovakia [1][4]. Group 1: Offering Details - The company plans to issue a minimum of 20,000,000 and a maximum of 24,000,000 Offered Shares [1]. - The Offered Shares will be available to purchasers in all Canadian provinces except Québec and outside Canada under specific exemptions, allowing for immediate trading without a resale hold period [2]. - A finder's fee of 7.0% of gross proceeds will be paid to arm's length parties, along with finder's warrants equal to 7.0% of the Offered Shares sold [3]. Group 2: Use of Proceeds - Proceeds from the Offering will be allocated for the exploration and development of the Lutila Gold Project, general corporate purposes, and working capital [4]. Group 3: Company Overview - BULGOLD Inc. is focused on gold exploration in Central and Eastern Europe, controlling three quartz-adularia epithermal gold projects in Bulgaria and Slovakia [5]. - As of February 28, 2026, the company had 49,132,335 issued and outstanding shares, with approximately 28.3% held by Founders, Directors, and Management [6].
ION Closes Upsized Non-Brokered Private Placement
TMX Newsfile· 2026-03-14 00:07
Core Viewpoint - Lithium ION Energy Limited has successfully closed a non-brokered private placement offering, raising gross proceeds of $1,409,500 through the issuance of 35,237,500 units at a price of $0.04 per unit [1][3]. Group 1: Offering Details - Each unit consists of one common share and one common share purchase warrant, with each warrant allowing the purchase of one common share at $0.05 within 24 months from the closing date [2]. - The company paid finder's fees totaling $44,070 and issued 1,101,750 finder's warrants to assist in the offering [3]. - All securities issued are subject to a four-month hold period expiring on July 14, 2026, in accordance with applicable securities laws [4]. Group 2: Use of Proceeds - The net proceeds from the offering will be used to explore new growth opportunities, maintain the existing exploration portfolio, and for general working capital [3]. Group 3: Related Party Transactions - Directors and/or officers of the company subscribed for a total of 3,250,000 units for gross proceeds of $130,000, which is classified as a related party transaction [5]. - The company is relying on exemptions from formal valuation and minority shareholder approval requirements due to the insider participation not exceeding 25% of the company's market capitalization [5]. Group 4: Stock Options - The company granted 7,000,000 incentive stock options to directors, officers, and consultants, each exercisable at $0.05 per share for five years [6]. - The stock options vest immediately and are subject to the terms of the incentive stock option plan and TSX Venture Exchange policies [6].
Red Canyon Announces Non-Brokered Private Placements for Gross Proceeds of up to C$3,500,000
Thenewswire· 2026-02-25 11:30
Core Viewpoint - Red Canyon Resources Ltd. is planning to raise up to $3,500,000 through two concurrent non-brokered private placements to support its exploration and advancement of copper and copper/gold projects in British Columbia and the Western United States [1][3]. Group 1: Private Placement Details - The first offering, known as the LIFE Offering, aims to raise up to $2,000,000 by selling up to 10,000,000 common shares at a price of $0.20 per share, with immediate tradeability upon issuance [1][4]. - The second offering, referred to as the Concurrent Offering, seeks to raise up to $1,500,000 through the sale of up to 7,500,000 units at a price of $0.20 per unit, where each unit consists of one common share and one-half of a common share purchase warrant [2][4]. Group 2: Use of Proceeds - The net proceeds from both offerings will be utilized for the exploration and advancement of the company's copper and copper/gold projects, as well as for working capital and general corporate purposes [3]. Group 3: Regulatory Compliance and Conditions - The LIFE Shares will be offered to residents in specific Canadian provinces and will be immediately tradeable under applicable Canadian securities legislation [4]. - The offerings are expected to close around March 20, 2026, subject to necessary regulatory approvals, including from the Canadian Securities Exchange [6]. Group 4: Related Party Transactions - Directors and officers of the company may participate in the offerings, which will be classified as a "related party transaction" and are expected to be exempt from certain formal valuation and minority shareholder approval requirements [7].
Quantum Battery Metals Corp. Announces Closing of $507,500 Non-Brokered Private Placement
TMX Newsfile· 2026-02-25 00:35
Core Viewpoint - Quantum Battery Metals Corp. has successfully closed a non-brokered private placement, raising gross proceeds of $507,500 through the issuance of 1,750,000 units at a price of $0.29 per unit [1][5]. Group 1: Offering Details - Each unit consists of one common share and one common share purchase warrant, with the warrant allowing the purchase of an additional common share at an exercise price of $0.40, valid for 12 months from the closing date [2]. - The warrants include an acceleration provision, which allows the company to expedite the expiry of the warrants if the common shares trade at a volume-weighted average price of at least $0.80 for five consecutive trading days [3]. Group 2: Use of Proceeds - The net proceeds from the offering will be allocated for exploration activities and general corporate and working capital purposes [5]. Group 3: Company Overview - Quantum Battery Metals Corp. focuses on the exploration and development of battery metals projects that are essential for the electric vehicle and renewable energy sectors, emphasizing responsible exploration and value-driven growth [7].
Cannabix Technologies Closes Non-Brokered Private Placement
Globenewswire· 2026-02-24 22:45
Core Viewpoint - Cannabix Technologies Inc. has successfully closed a non-brokered private placement financing, raising a total of CDN$700,000 through the issuance of 1,400,000 units at CDN$0.50 per unit [1] Group 1: Offering Details - Each unit consists of one common share and one non-transferable common share purchase warrant, with the warrants exercisable at CDN$0.65 for 24 months [1] - The company may accelerate the expiry of the warrants if the share price exceeds CDN$0.75 for 10 consecutive trading days [1] - The net proceeds from the offering will be used for manufacturing inventory, labor, general and administrative expenses, and unallocated working capital [2] Group 2: Regulatory Compliance - The offering was conducted under the Listed Issuer Financing Exemption, allowing units to be sold to Canadian residents (excluding Quebec) without resale restrictions [3] - An offering document dated February 6, 2026, is available on SEDAR+ and the company's website, providing additional details about the offering [4] Group 3: Insider Participation - The CEO acquired 126,000 units in the offering, which is classified as a related party transaction but is exempt from formal valuation and minority shareholder approval requirements [5] - The company plans to file a material change report related to the offering, which is necessary for expeditious completion [5] Group 4: Finder's Fees - The company paid CDN$7,360 in cash as finder's fees and issued 14,720 finder's warrants, each allowing the holder to acquire one share at CDN$0.65 for 24 months [6] Group 5: Investor Rights - An investor holds a contractual participation right until May 15, 2026, but has waived this right in connection with the offering [7]
Melkior Announces Proposed Non-Brokered Private Placement
Thenewswire· 2026-02-24 13:35
Core Viewpoint - Melkior Resources Inc. plans to raise up to $650,000 through a non-brokered private placement to fund exploration activities, including a 4,000-metre drill program at the Beschefer East Project [1]. Group 1: Private Placement Details - The private placement will involve the issuance of up to 5,416,666 flow-through common shares at a price of $0.12 per share [1]. - Each flow-through unit will consist of one flow-through share and one-half of a common share purchase warrant, with each whole warrant allowing the purchase of one additional common share at a price of $0.20 for two years [2]. - The proceeds from the sale of flow-through shares will be allocated to Canadian exploration expenses related to the company's mineral properties [3]. Group 2: Regulatory and Compliance Information - The company may pay a finder's fee to eligible arm's length finders in accordance with TSX Venture Exchange policies, and all securities issued will be subject to a four-month statutory hold period [4]. - Participation from certain directors and officers in the private placement is considered a related-party transaction, exempt from certain valuation and minority shareholder approval requirements [5]. - The securities issued will not be registered under the U.S. Securities Act and cannot be offered or sold in the U.S. without proper registration or exemption [6].
Appili Therapeutics Announces Closing of Second Tranche of Non-Brokered Private Placement
Globenewswire· 2026-02-18 12:19
Core Viewpoint - Appili Therapeutics Inc. has successfully closed the second tranche of a non-brokered private placement, raising gross proceeds of C$100,000 to support its drug development efforts for infectious diseases [1]. Group 1: Private Placement Details - The private placement involved the issuance of 4,000,000 units at a price of C$0.025 per unit, with each unit consisting of one Class A common share and one-half of a common share purchase warrant [2]. - Each whole warrant will allow the holder to acquire one common share at a price of C$0.05 for 36 months, pending shareholder approval [2][3]. - The company will seek shareholder approval for the warrants at the next Annual General Meeting, and if not approved, the warrants will not be exercisable [3]. Group 2: Use of Proceeds - The net proceeds from the private placement will primarily be used for working capital and to fund the development of certain product candidates [4]. Group 3: Broker Warrants - In connection with the closing, the company paid C$8,000 to finders and issued 320,000 broker warrants, which will allow holders to acquire common shares at a price of not less than C$0.02834 for 24 months, also subject to shareholder approval [4][5]. - Similar to the common warrants, the broker warrants will not be exercisable until shareholder approval is obtained [5]. Group 4: Company Overview - Appili Therapeutics is focused on developing therapies for life-threatening infections, with a portfolio that includes an FDA-approved treatment for antimicrobial resistant infections and a vaccine candidate for tularemia [7]. - The company aims to strategically develop a pipeline of novel therapies to address urgent infections with unmet needs [7].
Stinger Resources Inc. Completes Non-Brokered Private Placement
TMX Newsfile· 2026-02-13 23:30
Core Viewpoint - Stinger Resources Inc. has successfully closed a non-brokered private placement, raising a total of $160,000 by issuing 3,200,000 units at a price of $0.05 per unit [1]. Group 1: Offering Details - The private placement was announced on January 7, 2026, and involved no finder's fees [1]. - All securities issued under the Offering are subject to a hold period that expires on June 14, 2026, in accordance with CSE policies and applicable securities laws [2]. Group 2: Insider Participation - Certain directors and officers of the Company participated in the Offering, purchasing 1,400,000 units for gross proceeds of $70,000 [3]. - This insider participation is classified as a related party transaction and is exempt from formal valuation and minority shareholder approval requirements under MI 61-101, as the fair market value of the securities did not exceed 25% of the Company's market capitalization [3]. Group 3: Company Overview - Stinger Resources Inc. holds interests in gold and silver properties in British Columbia, including the 100% owned Dunwell Mine, which is located in the "Golden Triangle" [5]. - The Company also owns the Gold Hill property and the Silver Side property, along with an optioned interest in the Ample Goldmax property in British Columbia [6].
Vault Strategic Mining Corp Announces Non-Brokered Private Placement
Thenewswire· 2026-02-06 12:00
Core Viewpoint - Vault Strategic Mining Corp. has announced a non-brokered private placement of up to 2,000,000 units at a price of $0.25 per unit, aiming for gross proceeds of up to $500,000 [1][2]. Group 1: Private Placement Details - Each unit consists of one common share and one-half of a transferable common share purchase warrant, with each whole warrant allowing the purchase of an additional common share at an exercise price of $0.35 for twelve months [2]. - The net proceeds from the private placement will be used for exploration activities and general corporate purposes, with potential finders' fees applicable [3]. - All securities issued will be subject to a hold period of four months and one day as per applicable securities legislation [3]. Group 2: Warrant Provisions - The warrants include an acceleration provision, allowing the company to notify warrant holders to exercise their warrants if the weighted average daily trading price exceeds $0.60 for five consecutive trading days [4]. - If the acceleration notice is issued, warrants not exercised within 30 days will expire [4]. Group 3: Insider Participation - Any insider participation in the private placement will be considered a related party transaction, and the company will rely on exemptions from formal valuation and minority approval requirements [5].